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Abstract
Variation in human intelligence is approximately 50% heritable, but understanding of the genes involved is limited. Several
forms of genetic variation remain under-studied in relation to intelligence, one of which is copy number variation (CNV).
Using single-nucleotide polymorphism (SNP) -based microarrays, we genotyped CNVs genome-wide in a birth cohort of 723
New Zealanders, and correlated them with four intelligence-related phenotypes. We found no significant association for any
common CNV after false discovery correction, which is consistent with previous work. In contrast to a previous study,
however, we found no effect on any cognitive measure of rare CNV burden, defined as total number of bases inserted or
deleted in CNVs rarer than 5%. We discuss possible reasons for this failure to replicate, including interaction between CNV
and aging in determining the effects of rare CNVs. While our results suggest that no CNV assayable by SNP chips contributes
more than a very small amount to variation in human intelligence, it remains possible that common CNVs in segmental
duplication arrays, which are not well covered by SNP chips, are important contributors.
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Introduction
A large body of work comparing monozygotic and dyzygotic
twin sets indicates that approximately half of the variation in
human intelligence as measured by standard tests is genetic, with
estimates ranging between 40 and 80% [1,2,3,4,5,6]. Intelligence
is also remarkably tractable and stable, with different groups of
cognitive tests ranking participants very similarly [7]. As is the case
for many other heritable complex traits, however, individual
genetic polymorphisms explaining substantial proportions of
variation in intelligence-related phenotypes have not been
identified despite multiple large-scale studies [8,9,10]. Perhaps
surprisingly given the high heritability of testable intelligence, no
robust or consistent link with any gene has yet been found in
healthy individuals [11].
Prior to the emergence of high-throughput genotyping technol-
ogies, investigation of the genetics of intelligence focused on
particular candidate genes selected on the basis of known aspects
of gene function [12]. While many significant associations were
found by this approach, these results were not replicated by studies
from 2005 onwards that investigated thousands of polymorphisms
across the whole human genome [13,14,15,16,17]. The most
recent genome-wide association studies (GWAS), which have
assayed several hundred thousand common single-nucleotide
polymorphisms (SNPs) in as many as 11,000 people, have also
not consistently identified any SNP significantly associated with
intelligence after false discovery correction, and none which
explains more than a tiny fraction of its inter-individual variation
[8,9,10]. One plausible explanation for the failure of common
SNPs to account for the heritability of intelligence is that a large
number, perhaps many thousands, of genetic variants each
contribute a very small amount [2,8]. Similarly to most other
complex traits, the extent to which this explanation is correct is still
uncertain because other sources of genetic variation including rare
SNPs, microsatellite length polymorphisms, gene-gene and gene-
environment interactions, epigenetic modifications and copy
number variations remain under-explored [18].
Since 2004 genome-wide microarray technology and whole
genome sequencing have revealed that copy number variations
(CNVs), deletions or duplications of sections of DNA as large as
several mega bases, are present in all individuals and are
responsible for a large proportion of normal human genetic
variation, in fact more than SNPs in terms of numbers of variable
nucleotides [19,20,21,22]. Many CNV regions contain genes
related to development and intelligence [23,24,25], and large, rare
CNVs, have often been linked to schizophrenia, autistic spectrum
disorder, and other developmental disorders with associated
intellectual impairment [26,27,28,29,30,31,32]. Determining
pathogenicity of particular CNVs in individuals affected by these
disorders is often difficult or impossible because many variants
increase risk while still being present in healthy controls [33], and
in general the study of rare variants faces the problem that
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extremely large sample sizes are usually required to demonstrate
statistically significant associations [18]. However, both autistic
spectrum disorder and schizophrenia are significantly associated
with elevated total amounts of rare CNV genome-wide (CNV
burden) [30,31], which can be correlated with phenotype without
large sample sizes.
Body asymmetry, presumably reflecting mild developmental
perturbation, is associated with reduced intelligence in individuals
unaffected by clinically defined developmental disorders [34] and
as many as 80% of mammalian genes are expressed in the brain
[35]. These and other clues suggested the hypothesis that
increased CNV burden may cause a reduction in cognitive ability
in normal individuals, potentially via impaired development of
neuronal structures [36].This was recently tested in 74 otherwise
normal adults meeting criteria for alcohol dependence, and a
significant correlation between IQ score, measured by the
Wechsler abbreviated scale of intelligence [37] and CNV burden,
defined as number of bases deleted in CNVs with frequencies of
5% or less, was found (p = 0.01) [36]. Here we report a failure to
replicate this result in 717 individuals participating in the
Christchurch Health and Development study (CHDS), a birth
cohort consisting of children born in Christchurch New Zealand
within a four-month period during mid-1977.
Common CNVs, i.e. variants with population frequencies
greater than 5%, are also under-studied extensively in relation to
cognitive ability. To our knowledge there is only one published
GWAS, which examined 178 SNPs known to tag common CNVs
in 1250 individuals, and correlated them with 11 intelligence-
related phenotypes [38]. No significant associations were found
after multiple hypothesis correction, but an enrichment of low P
values encouraged further investigation. In addition to our study of
rare CNV burden, we report a GWAS of common CNV regions
versus scores on four different tests of intellectual ability and
academic achievement in the CHDS cohort. We have also not
identified any significant association after multiple hypothesis
correction, providing further evidence that no individual CNV
assayable by SNP-based chips has a substantial effect on
intelligence in normal populations.
Methods
CNV Genotyping and Analysis
CNVs were detected using SNP-based Illumina 660W-Quad
bead chips and called by PennCNV software following standard
QC procedures [39]. Automatic QC of CNV calls was performed
using program filter_cnv.pl from the PennCNV package with
default settings: qcbafdrift (B allele frequency drift) wass set at 0.01
and qcwf (waviness factor) was set at 0.05. At least three
consecutive positive probes were required for a CNV call.
Previously used standards of high individual CNV count,
potentially indicating DNA degradation, are 40 [40] and 80 CNVs
[41]. We used the lower threshold and excluded 137 individuals
with more than 40 CNVs from our GWAS, leaving a sample size
of 586. While the number of excluded individuals was clearly high,
our DNA samples were not generally of poor quality, since they
showed a failure rate of only 14 out of 761 in the SNP-based study
performed on the same chip data, which was the lowest among the
three cohorts used in the study. For the CNV burden tests, we
repeated the analyses using the whole dataset, as well as the filtered
set of 586 individuals, and this had no effect on the results.
Where CNVs overlapped, we used standard modules of the
Plink software package (version 1.07) to define them as identical or
separate, and to assign each CNV a frequency within the dataset.
Following Yeo et al., (2011) [36], we used 5% frequency as the
dividing line between rare and common CNVs. For our GWAS
we merged overlapping common CNVs into regions and scored
these regions as CNV or not CNV in each individual.
Tests of Intellectual Ability
Our test subjects were 723 individuals participating in the
Christchurch Health and Development study (CHDS), a birth
cohort consisting of children born in the Christchurch New
Zealand urban area within a four-month period during mid-1977.
The participants have been assessed at regular intervals using
various biological and behavioural measures [42,43]. Here we
have correlated CNVs with the following four tests of cognitive
ability/academic achievement:
WISC-R total IQ (8–9 years). Child cognitive ability was
assessed at ages 8, 9 years using the revised Wechsler Intelligence
Scale for Children [44]. Assessments were based on four verbal
and four performance subscales administered at each age. The
measure used in the present analysis is the average of the child’s
estimated total IQ scores from each assessment. (Mean
IQ = 104.7, SD = 13.9, range 63–144).
The test of scholastic abilities (13 years). The Test of
Scholastic Abilities (TOSCA) provides a measure of the extent to
which a child exhibits the skills and competencies necessary to deal
with the academic requirements of high school education [45]
(Mean TOSCA score = 36.4, SD = 14.8, range 0–69).
Burt word reading test (18 years). The Burt Word
Reading Test [46] provides a generalised measure of word
recognition ability. The test was administered at age 18, and the
total score calculated based on the number of words correctly
identified. (Mean Burt = 98.2, SD = 12.2, range 26–110).
Overall academic achievement (25 years). On the basis of
participant reports of their educational history and attainment of
qualifications sample members were classified on a 7-point scale
reflecting their highest level of academic attainment by age 25
years [47]. This scale ranged from 1 = no formal qualifications to
7 = attained a university degree. (Mean achievement score = 4.4,
SD, SD = 2.2).
Assessment of cognitive outcomes up to age 13 was limited to
the sub-sample of the cohort resident in the Canterbury region
(approximately 80% of the total available cohort at each age). As a
result the sample sizes assessed on the WISC-R and TOSCA are
somewhat lower than for the measures assessed in young
adulthood.
Alcohol Dependence
At ages 18, 21, 25 and 30 participants were questioned about
patterns of alcohol use/misuse since the previous assessment. As
part of this questioning relevant items from the Composite
International Diagnostic Interview [48] were used to assess DSM-
IV [49] diagnostic criteria for alcohol dependence. Participants
were classified as having alcohol dependence if they met diagnostic
criteria for dependence at any time from age 18–30 years.
Ethical Approval
All phases of the CHDS were subject to ethical approval from
the Canterbury (NZ) Regional Health and Disability Ethics
Committee and all aspects of data collection were with the written
consent of research participants.
Results
In 723 individuals we found a total of 22,249 CNVs with a
mean length of 60,867 base pairs (bp). Locations and genotypes of
all CNVs called can be found in Table S1. We made a division
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between rare and common CNVs with a threshold of 5%
frequency. With the rare CNVs, we performed an analysis of total
CNV burden, in terms of number of bases deleted or inserted per
individual, versus scores on four different tests of intellectual
ability. We also performed a GWAS of common CNVs, first
combining overlapping CNVs into CNV regions (CNVRs). There
were 53 CNVRs with greater than 5% frequency in our sample,
and we evaluated the effect of each of these against our cognitive
test scores using Pearson parametric correlation.
Rare CNV Burden Analysis
We first attempted to replicate the results of Yeo et al., (2011)
[36] who found a significant negative correlation between IQ
score and total number of bases deleted in CNVs below 5%
frequency [36]. In our filtered sample, individuals lost an average
of 309,618 bp (SD = 316,857) in 12.15 rare deletions (SD = 6.5).
These numbers are somewhat higher than those in the sample
studied by Yeo and colleagues [36], which likely reflects platform-
specific differences in sensitivity of CNV detection (Ronald Yeo,
personal communication). Table 1 shows the correlations between
selected measures of cognitive ability/academic achievement and
the number/size of rare CNVs in the CHDS cohort. The
measures of ability/achievement were selected to span the age
range from childhood to adulthood and included: 1) the full scale
WISC-R total IQ score assessed at ages 8–9 years; 2) the Test of
Scholastic Abilities (TOSCA) administered at age 13 years; 3) the
Burt Word Reading Test administered at age 18 years; and 4) a
global measure of academic achievement by age 25 years. We
selected these measures from a much broader array of cognitive/
academic outcomes, all of which exhibit the same general
properties in terms of absence of association with CNVs.
For each outcome the table shows the observed Pearson
correlations with three measures of rare CNV status: i) the length
of rare deletions; ii) the length of rare insertions; and iii) the total
number of rare CNVs. The correlations are estimated for each of
three samples: i) the total available gene chip sample assessed on
each cognitive/academic outcome; ii) the sample filtered to
exclude subjects with a high CNV count (over 40 CNVs); and
iii) the subset of the filtered sample who met DSM-IV diagnostic
criteria for alcohol dependence from age 18–30 years. None of
these correlations was statistically significant (P.0.1).
To examine the extent to which the findings may have been
influenced by the inclusion of subjects with moderate or severe
cognitive impairment, we re-analysed the data excluding all
subjects who scored more than two standard deviations below the
mean on the cognitive test measures. The resulting correlations
were negligibly different from those reported in Table 1. Further
analysis of residuals to identify and exclude a small number of
potential outliers also had little impact on the observed pattern of
correlations. In two cases the exclusion of outliers resulted in the
observed correlation increasing to the point of statistical signifi-
cance (p,0.05): these cases involved the correlation of academic
achievement with length of rare deletions (r = .11) and number of
rare CNVs (r = .10) in the sample filtered to exclude those with
high CNV count. These exceptions aside, the correlations
including or excluding outliers were otherwise very similar.
GWAS on Common CNV Regions
Table 2 summarizes our findings from examination of
correlations between cognitive/academic outcomes and the 53
CNVRs with more than 5% frequency in the dataset. The analysis
suggests an almost complete absence of association between the
CNV measures and each outcome. In each case tests of the
distribution of the correlations against a normal distribution using
Q-Q plots and goodness of fit tests showed that the distributions
were consistent with random sampling from a normal distribution
with mean zero.
Overall nine correlations were statistically significant at the
p,0.05 level, no more than would be expected by chance. Five of
these correlations were accounted for by two CNVRs: CNVR50
showed significant positive correlations with three of the four
outcomes, and CNVR17 significant negative associations with two
outcomes. However, after application of a Bonferroni correction
for multiple comparisons only one correlation (CNVR46 and











Length of rare deletions .02 .04 2.00 .02
Length of rare insertions 2.02 2.03 .02 2.03
Number of rare CNVs .03 .05 .01 .02
(N = 567) (N = 527) (N = 697) (N = 717)
Filtered sample excluding those with high (40+) CNV count
Length of rare deletions 2.04 .03 2.00 .03
Length of rare insertions 2.02 2.01 .04 2.01
Number of rare CNVs .02 .04 .04 .06
(N = 462) (N = 431) (N = 566) (N = 581)
Filtered sample meeting criteria for alcohol dependence
Length of rare deletions .09 .10 .04 .01
Length of rare insertions 2.07 2.06 .01 .04
Number of rare CNVs .03 2.02 .04 .06
(N = 64) (N = 56) (N = 83) (N = 87)
*All correlations statistically non-significant (p..10).
doi:10.1371/journal.pone.0055208.t001
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academic achievement, r = .14, p = 0.0005) reached significance
using the Bonferroni corrected p value (p = 0.0009), in association
with overall academic achievement at age 25. Further examination
showed that CNVR46 had negative and non-significant correla-
tions with other cognitive/achievement outcomes, suggesting that
this correlation could easily reflect chance variation in the data.
None of the nominally significant CNVRs overlapped with any
SNP listed as being significant at any level by three previous large
GWAS on cognitive ability [8,9,10]. Locations of the nominally
significant CNVRs and their gene contents can be found in Table
S2. Pseudogenes and genes of unknown function are the most
common gene types involved, and the remainder, including low
density lipoprotein and olfactory receptors, are of no obvious
relevance to cognitive ability.
Reanalysis of the data to exclude potential outliers or those with
moderate/severe cognitive impairment did not substantively alter
these findings. In each case the observed pattern of correlations
was consistent with those reported in Table 2. While a small
number of correlations were nominally significant at p,.05, no
correlation other than that between CNVR46 and academic
achievement exceeded the Bonferroni corrected significance value
(p,.0009).
Discussion
Our findings do not provide strong evidence for an association
between any common CNV region and cognitive/academic
performance scores, and we were unable to detect any effect of
rare CNV burden on these outcomes. Given previous evidence
that CNVs can affect intelligence-related phenotypes, the most
obvious explanation for our negative results is that we didn’t
sample a sufficient number of functional CNVs. In view of the fact
that we couldn’t detect any enrichment of non-significant
correlations, we cannot argue that testing a larger number of
individuals by our methods would reveal significant associations.
However, it is likely that our chip probes missed some important
variants, particularly segmental duplication arrays, as these are not
easily assayable by SNP chips or other standard genotyping
methods [50,51,52]. One example of this is the CNV encoding
repeats of a protein domain of unknown function called DUF1220
on Chromosome 1q21.1 [53]. The size of this duplication array
correlates well with brain size between species [23,54], as well as
within the human population [55,56], but because it has increased
dramatically in copy number during the evolution of the primate
lineage it has too many copies to assay accurately by normal high-
throughput methods. Consistent with the previous published
GWAS of CNV and cognitive measures, which also didn’t identify
any significant associations after false discovery correction [38],
our results encourage focus on these less accessible CNVs.
In general, common variants are expected to have smaller
phenotypic effects than rare ones [57] and CNVs that have been
associated with intellectual and developmental impairment are
predominantly large, rare de novo mutations rather than commonly
segregating alleles [28,29,58]. It’s therefore less clear why we were
unable to replicate the significant association found by Yeo and
colleagues between rare CNV burden and intelligence [36]. Our
much larger sample size suggests that our results should be
considered more reliable, but methodological differences may be
relevant. A recent large twin study reported that heritability of
general cognitive ability increases significantly and linearly from
41% in childhood (9 years) to 55% in adolescence (12 years) and to
66% in young adulthood (17 years) [3], and strong evidence is
emerging that genetics makes a substantial contribution to changes
in intelligence from childhood to old age [59]. Yeo et al., (2011)
[36] tested IQ score at ages ranging between 22 and 55, and our
measures were taken at 8–9, 13, 18 and 25 years, with IQ only
sampled at ages 8–9. It may therefore be that the rare CNVs that
caused the association they found were related to an interaction
between CNV, age and cognitive ability, and future studies should
account for this possibility by including age as a co-factor or
stratifying samples by age group. Although their sample was
restricted to alcohol-dependent individuals, a substantial contri-
bution by alcoholism is unlikely since we found no significant
correlations for the subset of our cohort meeting diagnostic criteria
for alcohol dependence (DSM-IV) [49], albeit with small sample
sizes of 64–87 individuals.
Theoretically, it is also possible that population-specific variants
were involved. However, while our study participants were born in
New Zealand and Yeo et al. (2011) [36] studied North Americans,
the subset of their sample showing the largest association with rare
CNV burden was the 45% classified as Anglo/White, and these
individuals should be more similar to our cohort, the majority of
whom are of British descent, than to other ethnicities in their
sample. Effects of sex also do not explain the discrepancy, since
although Yeo and colleagues [36] sampled 53 males and only 21
females, we found no difference between the sexes in the effect of
CNV burden (data not shown).
In conclusion, our results are in line with previous work showing
that individual common variants assayable by SNP chips do not
have strong effects on cognitive ability, and suggest that total
Table 2. Summarizing the distribution of correlations between measures of cognitive ability/academic achievement and 53
CNVRs.





WISC-R Total IQ score (8–9 years,
N = 462)
.005 (.044) 2.088, .113 CNVR50 (r = .11)
TOSCA (13 years, N = 431) 2.000 (.051) 2.110, .114 CNVR5 (r = 2.11); CNVR17 (r = 2.10);
CNVR43 (r = 2.11); CNVR49 (r = .10);
CNVR50 (r = .11)
Burt Word Reading Test (18 years,
N = 566)
2.002 (.041) 2.081, .063
Overall academic achievement
(25 years, N = 581)
.007 (.050) 2.120, .144 CNVR17 (r = 2.12); CNVR46 (r = .14);
CNVR50 (r = .09)
CNVR46 (r = .14)
doi:10.1371/journal.pone.0055208.t002
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burden of rare CNVs is also not a major contributor. There are
currently more promising approaches to elucidating the genetic
component of intelligence. These include larger studies to identify
individual functional rare variants, new statistical methods
allowing evaluation of the effects of agglomerations of common
variants [8], and testing of other under-studied sources of genetic
variation such as promoter microsatellites and segmental duplica-
tion arrays, as well as gene-gene and gene-environment interac-
tions.
Supporting Information
Table S1 All CNV data. Genomic coordinates are HG18.
(XLS)
Table S2 Locations and gene contents of CNVRs
associated with cognitive measures at a nominal level
(P,0.05). No P values were significant after false discovery
correction. Coordinates are HG18.
(XLS)
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